<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="app1table1" position="float"><object-id pub-id-type="doi">10.7554/eLife.30334.018</object-id><label>Appendix 1&#8212;table 1.</label><caption><title>Normalization model parameters.</title><p>Arbitrary units abbreviated as a.u. Lorazepam abbreviated LZ. <sup>+</sup>Indicates parameters that were adjusted in order to fit the data, as opposed to those that were fixed to match the stimuli. Changes in contrast gain were modeled by varying stimulus contrast (e.g. stimulus contrast for the LZ model is the square root of the contrast for the placebo model). Response gain changes were modeled through the inclusion of a parameter that scaled the predicted response (<italic>A</italic>). For the MRS model, the effect of hMT+ GABA was modeled by varying the response criteria (lower value is 80% of the higher criterion).</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">Parameter name</th><th colspan="3" valign="top">Parameter value</th></tr><tr><th valign="top"/><th valign="top">Basic model</th><th valign="top">Lorazepam model</th><th valign="top">hMT+&#160;GABA MRS model</th></tr></thead><tbody><tr><td valign="top">Stimulus contrast</td><td valign="top">0.03 or 0.98</td><td valign="top">0.03 or 0.98 (placebo), <break/>0.017 or 0.099 (LZ)</td><td valign="top">0.03 or 0.98</td></tr><tr><td valign="top">Stimulus spatial center (<italic>x</italic>, a.u.)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">0</td></tr><tr><td valign="top">Stimulus spatial width (a.u.)</td><td valign="top">1, 2, or 12</td><td valign="top">0.84, 1.7, or 10</td><td valign="top">0.84, 1.7, or 10</td></tr><tr><td valign="top">Stimulus orientation (<italic>&#952;</italic>, &#176;)</td><td valign="top">90</td><td valign="top">90</td><td valign="top">90</td></tr><tr><td valign="top">Stimulus orientation width (&#176;)</td><td valign="top">5</td><td valign="top">5</td><td valign="top">5</td></tr><tr><td valign="top">Excitatory spatial pooling width (<italic>x<sub>w_e</sub></italic>, a.u.)<sup>+</sup></td><td valign="top">5</td><td valign="top">6.5</td><td valign="top">4.5</td></tr><tr><td valign="top">Excitatory orientation pooling width (<italic>&#952;<sub>w_e</sub></italic>, &#176;)<sup>+</sup></td><td valign="top">25</td><td valign="top">5</td><td valign="top">25</td></tr><tr><td valign="top">Suppressive spatial pooling width (<italic>x<sub>w_s</sub></italic>, a.u.)<sup>+</sup></td><td valign="top">40</td><td valign="top">40</td><td valign="top">15</td></tr><tr><td valign="top">Suppressive orientation pooling width (<italic>&#952;<sub>w_s</sub></italic>, &#176;)<sup>+</sup></td><td valign="top">50</td><td valign="top">25</td><td valign="top">50</td></tr><tr><td valign="top">Semi-saturation constant <break/>(<italic>&#963;</italic>, a.u.)<sup>+</sup></td><td valign="top">0.0002</td><td valign="top">0.0001</td><td valign="top">0.0001</td></tr><tr><td valign="top">Criterion (at 3% contrast, a.u.)<sup>+</sup></td><td valign="top">300</td><td valign="top">775</td><td valign="top">300 (higher), <break/>240 (lower)</td></tr><tr><td valign="top">Criterion (at 98% contrast, a.u.)<sup>+</sup></td><td valign="top">650</td><td valign="top">775</td><td valign="top">375 (higher), <break/>300 (lower)</td></tr><tr><td valign="top">Response scalar (<italic>A</italic>, a.u.)<sup>+</sup></td><td valign="top">N/A</td><td valign="top">1 (placebo), 0.85 (LZ)</td><td valign="top">N/A</td></tr></tbody></table></table-wrap>